Functional hepatic recovery after xenotransplantation of cryopreserved fetal liver cells or soluble cell-factor administration in a cirrhotic rat model: Are viable cells necessary?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 7 PT2, 2008, Pages

  Ochenashko, Olga V ^a   Nikitchenko, Yurii V ^b   Volkova, Nataliya A ^a   Mazur, Svetlana P ^a   Somov, Alexander Y ^a   Fuller, Barry J ^c   Petrenko, Alexander Y ^a  

^a INSTITUTE FOR PROBLEMS OF CRYOBIOLOGY AND CRYOMEDICINE   (Ukraine)

^b V N KARAZIN KHARKIV NATIONAL UNIVERSITY   (Ukraine)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cell transplantation; Cirrhosis; Cryopreservation; Fetal specific factors; Human fetal liver cell; Liver progenitor cells

Indexed keywords

ALBUMIN; BILIRUBIN; CARBON TETRACHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CRYOPRESERVATION; DETOXIFICATION; DISEASE MODEL; FETUS; FETUS LIVER; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; LIVER CELL; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER HISTOLOGY; LIVER MITOCHONDRION; LIVER REGENERATION; LIVER STRUCTURE; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; XENOTRANSPLANTATION;

EID: 47649131319     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05095.x     Document Type: Article

References (40)

1. Riordan S, Williams R. Transplantation of primary and reversibly immortalized human liver cells and other gene therapies in acute liver failure and decompensated chronic liver disease. World J. Gastroenterol. 2000 6 : 636 42.
2. 4-induced cirrhosis. Cell Transplant. 2006 15 : 23 33.
3. Taniguchi H, Kondo R, Suzuki A et al. Evidence for the presence of hepatic stem cells in the murine fetal liver. Transplant. Proc. 1999 31 : 454.
4. Suzuki A, Zheng Y, Kaneko S et al. Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J. Cell Biol. 2002 156 : 173 84.
5. Roy V, Miller JS, Verfaillie CM. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Exp. Hematol. 1997 25 : 387 94.
6. Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000 6 : 1229 34.
7. Theise ND, Badve S, Saxena R et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000 31 : 235 40.
8. Wang X, Ge S, McNamara G et al. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood 2003 101 : 4201 8.
9. Sharma AD, Cantz T, Richter R et al. Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver. Am. J. Pathol. 2005 167 : 555 64.
10. Sennikov SV, Krysov SV, Silkov AN et al. Production of IL-10, TNF-alpha, IFN-gamma, TGF-beta1 by different populations of erythroid cells derived from human embryonal liver. Cytokine 2002 17 : 221 5.
11. Sennikov SV, Krysov SV, Injelevskaya TV. Production of cytokines by immature erythroid cells derived from human embryonic liver. Eur. Cytokine Netw. 2001 12 : 274 9.
12. Yao Z, Yang W, Zhang W et al. Human hepatic regenerative stimulator substance: partial purification and biological characterization of hepatic stimulator substance from human fetal liver cells. Hepatology 1990 12 : 1444 51.
13. Yasuda H, Imai E, Shiota A. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996 24 : 636 42.
14. Xue F, Takahara T, Yata Y et al. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 2003 52 : 694 700.
15. Jiang B, Kasai S, Sawa M et al. Beneficial effect of hepatic stimulatory substances on the survival of intrasplenically translanted hepatocytes. Cell Transplant. 1993 2 : 325 9.
16. Petrenko A, Sukach A. Isolation of intact mitochondria and hepatocytes using vibration. Anal. Biochem. 1991 194 : 326 9.
17. Kravchenko L, Petrenko A, Fuller B. A simple non-enzymatic method for the isolation of high yields of functional rat hepatocytes. Cell Biol. Int. 2002 26 : 1003 6.
18. Matsubara T, Koike M, Touchi A et al. Quantitative determination of cytochrome P-450 in rat liver homogenate. Anal. Biochem. 1976 75 : 596 603.
19. Nash T. Colorimetric estimation of formaldehyde by means of the Hartzsch reaction. Biochem. J. 1959 55 : 416 21.
20. Matsubara T, Touchi A, Tochino Y. Hepatic aminopyrine-N-demethylase system: further studies of assay procedure. Jpn. J. Pharmacol. 1977 27 : 127 36.
21. Imai Y, Ito A, Sato R. Evidence for biochemically different types of vesicles in the hepatic fraction. J. Biochem. (Tokyo) 1966 60 : 417 28.
22. Lowry O, Roseborough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951 193 : 265 75.
23. Muriel P. Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem. Pharmacol. 1998 56 : 773 9.
24. Iredale JP, Benyon RC, Pickering J et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 1998 102 : 538 49.
25. Issa R, Zhou X, Constandinou CM et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 2004 126 : 1795 808.
26. Somerset DA, Jauniaux E, Strain AJ et al. Hepatocyte growth factor concentration in maternal and umbilical blood samples and expression in fetal liver. J. Soc. Gynecol. Investig. 2000 7 : 333 7.
27. Zaret K. Early liver differentiation: genetic potentiation and multilevel growth control. Curr. Opin. Genet. Dev. 1998 8 : 526 31.
28. Cremones RV, Pereira-Filho AA, Magalhaes R et al. Experimental cirrhosis induced by carbon tetrachloride inhalation: adaptation of the technique and evaluation of lipid peroxidation. Arq. Gastroenterol. 2001 38 : 40 7.
29. Ferre N, Camps J, Cabre M, Paul A, Joven J. Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis. Metabolism 2001 50 : 997 1000.
30. Cherkashina D, Semenchenko O, Fuller B et al. Supplementation with fetal-specific factors ameliorates oxidative liver damage during hypothermic storage and reperfusion in a rat model. Cell Preserv. Technol. 2005 3 : 203 12.
31. Chu K, Kim M, Jeong S-W et al. Human neural stem cells can migrate, differentiate and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci. Lett. 2003 343 : 129 33.
32. Groen AK, Wanders RJ, Westerhoff HV et al. Quantification of the contribution of various steps to the control of mitochondrial respiration. J. Biol. Chem. 1982 257 : 2754 7.
33. ViLleneuvel JP, Pichette V. Cytochrome P450 and liver diseases. Curr. Drug Metab. 2004 5 : 273 82.
34. Imaoka S, Inoue K, Funae Y. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography. Arch. Biochem. Biophys. 1988 65 : 159 70.
35. Bastien MC, LeBlond F, Pichette V, Villeneuve JP. Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis. Can. J. Physiol. Pharmacol. 2000 78 : 912 19.
36. Okazaki I, Watanabe T, Hozawa S. Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery. Keio J. Med. 2001 50 : 58 65.
37. Masuhara M, Yasunaga M, Tanigawa K et al. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatology 1996 24 : 323.
38. Simeonova P, Gallucci R, Hulderman T et al. The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol. Appl. Pharmacol. 2001 177 : 112 20.
39. Shi MN, Huang YH, Zheng WD et al. Relationship between transforming growth factor beta1 and anti-fibrotic effect of interleukin-10. World J. Gastroenterol. 2006 12 : 2357 62.
40. Makowka L, Falk RE, Blendis LM et al. Use of liver cytosol fractions in treatment of acute liver failure. Surgery 1982 91 : 120 2.